BioMimics 3D Vascular Stent System
Peripheral Artery Disease (Femoropopliteal lesions)
ApprovedActive
Key Facts
Indication
Peripheral Artery Disease (Femoropopliteal lesions)
Phase
Approved
Status
Active
Company
About Veryan Medical
Veryan Medical is a commercial-stage medical device company focused on revolutionizing peripheral artery disease (PAD) treatment through its proprietary BioMimics 3D helical stent technology. The stent's design, based on pioneering research from Imperial College London, aims to improve long-term patency by promoting beneficial swirling blood flow, which may reduce restenosis and stent failure. With FDA and CE Mark approvals, the company is commercializing its flagship product, supported by a growing body of clinical evidence from its MIMICS registry program. As part of Otsuka Medical Devices, Veryan leverages the resources of a larger healthcare group to expand its market reach.
View full company profile